spacer
home > pmps > winter 2003 > monitoring pharmaceuticals during storing, handling and transportation by means of indicators
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Monitoring Pharmaceuticals During Storing, Handling and Transportation by Means of Indicators

Many goods are sensitive to sudden and/or lasting changes in circumstances during storing, handling and transportation. Humidity could get too high; a shock could occur; the temperature could drop; all kinds of variables that may influence the quality of goods when they are no longer within their individual stated specs or conditions. The longer they are out of that range, the more the quality is reduced. The need to use any means to monitor a shipment can have several reasons. It may be prescribed by regulations or by law, but can also be something a company wishes to implement themselves.

Indicators Versus Recorders

We are living in 2004, a high-tech world in which people almost automatically go for recorders to give precise data when monitoring of goods is required. Recorders nowadays fulfil the need for reliable record keeping, verification and traceability, however they also have disadvantages:


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Peter Van Buren, Sales Director at Introtech bv and Co-Director at Blanken Controls bv

Peter van Buren is Sales Director at IntroTech, responsible for (global) market expansion and distributor training and support on Temperature Indicators. He is also Co-Director at Blanken Controls, where he is involved with measurement and control equipment. Both companies are based in Holland and ISO9001 certified. The combination of both product lines has given Peter unique experiences in monitoring perishable and fragile goods in storage and shipment over the past 12 years. He has given many presentations on this topic and has often worked as a consultant in the area.

spacer
Peter van Buren
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Breakthrough in the global battle against polio: AJ Vaccines granted WHO prequalification for new polio vaccine

Despite ongoing concerted efforts to eradicate polio, it appears to be on the rise again with more cases registered in 2019 than 2018. Looking ahead, AJ Vaccines’ dose sparing technology provides a significant opportunity to expand supply, with the potential to deliver up to 100 million doses over the five-year period 2020-2024 to help meet the currently unmet global demand for inactivated polio vaccines.
More info >>

White Papers

Mouse Models for Evaluation of Vaccines and Therapeutics Against Staphylococcal Infections

IBT Bioservices

Introduction Staphylococcus aureus (SA) is a ubiquitous, formidable Gram-positive pathogen associated with skin and soft tissue, as well as lifethreatening systemic infections. SA is a leading cause of hospital- and community-associated infections worldwide, affecting humans and animals. The wide range of pathologies reflects the diverse abilities of this microbe to escape the innate and adaptive immune response using virulence factors. Since its first emergence in the 1960s methicillin-resistant SA (MRSA) has become endemic in hospitals and healthcare settings worldwide. In the 1990s, community associated MRSA strains (CA-MRSA) emerged, and are spreading worldwide posing a major global challenge.
More info >>

 
Industry Events

Formulation and Drug Delivery Series UK

8-9 July 2020, Oxford Global

This event brings together leading formulation, drug delivery and biologics manufacturing experts from around the world across two days. The panel of prominent industry leaders and world-leading scientists will share the latest case studies, innovative developments for novel therapeutic products and strategies for drug development.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement